Mark H. Zangmeister Center — Columbus, Ohio

Mark H. Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mark H. Zangmeister Center has participated in 6 clinical trials.

Therapeutic areas: Advanced Solid Tumours, Small Cell Lung Cancer, Carcinoma, Non-Squamous Non-Small Cell Lung.

Sponsors: Impact Therapeutics, Inc., Hoffmann-La Roche, Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mark H. Zangmeister Center?

Mark H. Zangmeister Center has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mark H. Zangmeister Center conducted?

Mark H. Zangmeister Center has 6 clinical trials on record. Their work covers Advanced Solid Tumours, Small Cell Lung Cancer, Carcinoma, Non-Squamous Non-Small Cell Lung.

Is Mark H. Zangmeister Center accredited by Crixeo Health?

Mark H. Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mark H. Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.